Evidence Based Current Management of Salivary Gland Tumours
Salivary gland tumours make up about 6% of head and neck tumours. They have a wide range of presentations, with about 80% being benign and the rest being malignant (typically in patients >60 years of age). The diagnosis and treatment of salivary gland tumours remain complex and present a challenging problem for the head and neck surgeon. Surgery is the primary treatment for malignant tumours. This is often combined with postoperative radiotherapy, depending on the specific tumour characteristics and stage. Salivary gland tumours respond poorly to chemotherapy. This talk by Mr J Bernstein, Consultant in Otolaryngology - Head and Neck Surgery at the Imperial College Healthcare NHS Trust, London, will discuss the clinical presentation, surgical anatomy, pathology and the management options of these tumours. Operative ‘tips and pearls’ will also be provided.
Mr Jonathan Bernstein MBChB, MD, FRCS
Consultant in Otolaryngology, Head and Neck Surgery, Imperial College Healthcare NHS Trust, London, Honorary Clinical Senior Lecturer, Imperial College London